George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.

Producer: Doni Holloway.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com